Price T Rowe Associates Inc Longboard Pharmaceuticals, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,909,257 shares of LBPH stock, worth $174 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,909,257

Previous 2,508,536 15.97%

Holding current value

$174 Million

Previous $67.8 Million 43.0%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.58 - $39.5 $11.1 Million - $15.8 Million	400,721 Added 15.97%	2,909,257 $97 Million
Q2 2024 Aug 14, 2024	BUY	$17.0 - $27.03 $4.94 Million - $7.85 Million	290,541 Added 13.1%	2,508,536 $67.8 Million
Q1 2024 May 15, 2024	BUY	$18.89 - $26.06 $11.2 Million - $15.4 Million	591,013 Added 36.33%	2,217,995 $47.9 Million
Q4 2023 Feb 14, 2024	SELL	$3.68 - $6.5 $534,946 - $944,879	-145,366 Reduced 8.2%	1,626,982 $9.81 Million
Q3 2023 Nov 14, 2023	BUY	$5.49 - $7.49 $444,788 - $606,824	81,018 Added 4.79%	1,772,348 $9.86 Million
Q2 2023 Aug 14, 2023	BUY	$4.19 - $10.05 $949,269 - $2.28 Million	226,556 Added 15.47%	1,691,330 $12.4 Million
Q1 2023 May 15, 2023	SELL	$3.84 - $5.96 $177,358 - $275,274	-46,187 Reduced 3.06%	1,464,774 $5.76 Million
Q4 2022 Feb 14, 2023	BUY	$2.95 - $5.5 $3,498 - $6,523	1,186 Added 0.08%	1,510,961 $4.78 Million
Q3 2022 Nov 14, 2022	SELL	$2.95 - $4.7 $5,793 - $9,230	-1,964 Reduced 0.13%	1,509,775 $5.62 Million
Q2 2022 Aug 15, 2022	SELL	$2.96 - $5.38 $1,480 - $2,690	-500 Reduced 0.03%	1,511,739 $4.67 Million
Q1 2022 May 16, 2022	SELL	$4.0 - $6.0 $2.05 Million - $3.07 Million	-512,377 Reduced 25.31%	1,512,239 $7.85 Million
Q4 2021 Feb 14, 2022	SELL	$4.75 - $9.45 $1.24 Million - $2.46 Million	-260,674 Reduced 11.41%	2,024,616 $9.8 Million
Q3 2021 Nov 15, 2021	SELL	$8.65 - $11.36 $17,291 - $22,708	-1,999 Reduced 0.09%	2,285,290 $20.4 Million
Q2 2021 Aug 16, 2021	SELL	$7.95 - $17.3 $122,907 - $267,458	-15,460 Reduced 0.67%	2,287,289 $20.1 Million
Q1 2021 May 17, 2021	BUY	$16.0 - $16.89 $36.8 Million - $38.9 Million	2,302,749 New	2,302,749 $36.2 Million

Others Institutions Holding LBPH

# of Institutions

126

Shares Held

34.9M

Call Options Held

28.9K

Put Options Held

13.9K

View Full List

About Longboard Pharmaceuticals, Inc.

Ticker LBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,586,000
Market Cap $815M
Description
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...

More about LBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Longboard Pharmaceuticals, Inc. Transaction History